Novo Nordisk to Slash Insulin Prices by Up to 75%

It is the latest move by a drugmaker to make steep reductions in list prices amid pressure to curb diabetes-treatment costs.

The Wall Street Journal | Compras / Ventas, Finanzas | Farmacia |

Leer noticia completa en el medio original
Spanish